Bidenoside C
25 mg
| Purity Not Available
TargetMol
Bidenoside C is a flavonoid found in brazilian propolis, the first of its kind to be isolated from a herb of the genus Leech, and has anti-proliferative activity against cancer cells.
More Information
Supplier Page
Bidenoside C
50 mg
| Purity Not Available
TargetMol
Bidenoside C is a flavonoid found in brazilian propolis, the first of its kind to be isolated from a herb of the genus Leech, and has anti-proliferative activity against cancer cells.
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
Bidwillol A
1 mL
| Purity Not Available
TargetMol
Bidwillol A
5 mg
| Purity Not Available
TargetMol
Bidwillon A
1 mg
| Purity Not Available
TargetMol
Bidwillon A
5 mg
| Purity Not Available
TargetMol
TargetMol
Biebrich scarlet is a scarlet dye, it has been used in Masson’s trichrome stain for the staining of collagen. It has also been used for the staining of eosinophil.
More Information
Supplier Page
TargetMol
Biebrich scarlet is a scarlet dye, it has been used in Masson’s trichrome stain for the staining of collagen. It has also been used for the staining of eosinophil.
More Information
Supplier Page
Bietamiverine
5 mg
| Purity Not Available
TargetMol
TargetMol
Bietanautine
100 mg
| Purity Not Available
TargetMol
Bietanautine
500 mg
| Purity Not Available
TargetMol
Bietaserpine
5 mg
| Purity Not Available
TargetMol
Bietaserpine
50 mg
| Purity Not Available
TargetMol
Bietaserpine
100 mg
| Purity Not Available
TargetMol
Bifarcept
5 mg
| Purity Not Available
TargetMol
Bifarcept is a recombinant antibody of interferon receptor type I ( IFN-RI ). Bifarcept can bind IFN-β and prolong its serum half-life [1] .
More Information
Supplier Page
Bifarcept
50 mg
| Purity Not Available
TargetMol
Bifarcept is a recombinant antibody of interferon receptor type I ( IFN-RI ). Bifarcept can bind IFN-β and prolong its serum half-life [1] .
More Information
Supplier Page
Bifemelane
5 mg
| Purity Not Available
TargetMol
Bifemelane is a nootropic compound that causes the first peak by stimulating release from intracellular Ca 2+ stores and the second by capacitive entry via store–operated Ca 2+ channels. Bifemelane will be offered as a pharmacological tool for basic research on astrocytes [1].
More Information
Supplier Page
Bifemelane
50 mg
| Purity Not Available
TargetMol
Bifemelane is a nootropic compound that causes the first peak by stimulating release from intracellular Ca 2+ stores and the second by capacitive entry via store–operated Ca 2+ channels. Bifemelane will be offered as a pharmacological tool for basic research on astrocytes [1].
More Information
Supplier Page
Bifemelane
100 mg
| Purity Not Available
TargetMol
Bifemelane is a nootropic compound that causes the first peak by stimulating release from intracellular Ca 2+ stores and the second by capacitive entry via store–operated Ca 2+ channels. Bifemelane will be offered as a pharmacological tool for basic research on astrocytes [1].
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
Bifenazate is a positive allosteric modulator of GABA receptor. Bifenazate is an acaricide that controls 100% of mites at a concentration of 25 ppm.
More Information
Supplier Page
TargetMol
Bifenazate is a positive allosteric modulator of GABA receptor. Bifenazate is an acaricide that controls 100% of mites at a concentration of 25 ppm.
More Information
Supplier Page
TargetMol
Bifenazate-diazene is a major degradation product of Bifenazate. Bifenazate is a selective carbazate acaricide and an insecticide [1] .
More Information
Supplier Page
TargetMol
Bifenazate-diazene is a major degradation product of Bifenazate. Bifenazate is a selective carbazate acaricide and an insecticide [1] .
More Information
Supplier Page
TargetMol
Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury.
More Information
Supplier Page
TargetMol
Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury.
More Information
Supplier Page
TargetMol
Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury.
More Information
Supplier Page
TargetMol
Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury.
More Information
Supplier Page
Bifeprunox
5 mg
| Purity Not Available
TargetMol
Bifeprunox is a potent partial agonist of dopamine D2-like and 5-HT1A receptor (pEC50: 6.37 for hippocampus 5-HT1A; pKis: 7.19 and 8.83 for cortex 5-HT1A and striatum D2). It is an antipsychotic for the research of schizophrenia.
More Information
Supplier Page
Bifeprunox
50 mg
| Purity Not Available
TargetMol
Bifeprunox is a potent partial agonist of dopamine D2-like and 5-HT1A receptor (pEC50: 6.37 for hippocampus 5-HT1A; pKis: 7.19 and 8.83 for cortex 5-HT1A and striatum D2). It is an antipsychotic for the research of schizophrenia.
More Information
Supplier Page
Bifeprunox
100 mg
| Purity Not Available
TargetMol
Bifeprunox is a potent partial agonist of dopamine D2-like and 5-HT1A receptor (pEC50: 6.37 for hippocampus 5-HT1A; pKis: 7.19 and 8.83 for cortex 5-HT1A and striatum D2). It is an antipsychotic for the research of schizophrenia.
More Information
Supplier Page
TargetMol
Bifeprunox is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Bifeprunox influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.
More Information
Supplier Page
TargetMol
Bifeprunox is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Bifeprunox influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.
More Information
Supplier Page
TargetMol
Bifeprunox is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Bifeprunox influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.
More Information
Supplier Page